Doctor Kobinger, you recently said: “Canada's approach is we're going to let others develop and we're going to buy cheap. It's a developing country approach.”
I guess the fact that Canada is the only G7 country to take doses from COVAX is an illustration of this.
This approach is not new. As in many other areas, especially basic research, the pandemic has shown us that chronic underfunding over the past several decades and under several governments has caused the current situation.
Can you tell us more about the effects of this underfunding of basic research on the ability to deal with COVID-19 and to produce vaccines that match the expertise of our researchers?